Best drainage method after burr hole evacuation for chronic subdural hematoma
Official title: Active 24 Hours Subperiostal vs. 24 Hours Passive Subdural Drainage Following Burr Hole Evacuation of Chronic Subdural Hematoma (the SUPERDURA Trial) - Protocol for a Nationwide Randomized Clinical Non-inferiority Trial
Run by Aalborg University Hospital · NCT06621407 · Data updated 2026-11-12
This trial tests whether 24 hours of active subperiosteal drainage works as well as 24 hours of passive subdural drainage for adults having a single burr‑hole evacuation of a symptomatic chronic subdural hematoma.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 354 (estimated) |
| Sponsor | Aalborg University Hospital Academic / other |
| Locations | 4 sites (Aalborg and 3 other locations) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | August 2027 |
| Study ends | November 2027 |
| Registry record updated | November 25, 2025 |
| Trial ID | NCT06621407 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with symptomatic chronic subdural hematoma admitted to a participating Danish neurosurgical unit for single burr‑hole evacuation who can give informed consent are ideal candidates.
✕Probably not a fit
Patients with recurrent CSDH, known CSF abnormalities, prior intracranial surgery or other major brain pathology, or those unable to provide informed consent are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter randomized non‑inferiority trial run across all Danish neurosurgical units comparing two 24‑hour drainage strategies after single burr‑hole evacuation of symptomatic chronic subdural hematoma. Eligible adult patients able to give informed consent are randomized to either active subperiosteal drainage or passive subdural drainage, with bilateral cases recorded and treated similarly on both sides. Key exclusions include recurrent CSDH, known cerebrospinal fluid abnormalities, prior intracranial pathology requiring surgery, and inability to consent. The trial aims to standardize practice by directly comparing outcomes such as recurrence and mortality between the two drainage methods.
Why it matters
Potential benefit: If successful, the results could simplify and standardize postoperative drainage practice and potentially reduce recurrence or complications after evacuation.
How similar studies have gone: Previous smaller or single‑center studies have compared drain placement and drainage methods with mixed or inconclusive results, so a national randomized trial is being done to provide definitive evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (≥ 18 years). * Patients with symptomatic CSDH confirmed on brain CT- or magnetic resonance imaging (MRI), admitted to a Danish neurosurgical department for surgical treatment. * Patients undergoing a single burr-hole evacuation. * Informed written and oral consent is taken prior to surgery. Exclusion Criteria: * Patients who are mentally incapacitated * Patients with known abnormalities in their cerebrospinal fluid (protein and glucose levels, cell count, and type) * Patients with changes or abnormalities in their normal cerebrospinal fluid dynamics, e.g., obstructive hydrocephalus, normal pressure hydrocephalus, intracranial hypotension, and ventricular peritoneal shunt. * Patients with additional/previously intracranial pathology that requires/has required neurosurgical treatment (e.g., brain tumor, vascular malformation, abscess). * Patients with recurrent CSDH or with previous craniotomy or other transcranial surgery (for any reason) * Patients unable to give consent prior to surgery
Where it's running
-
Department of Neurosurgery, Aalborg University Hospital
Aalborg, Denmark Recruiting -
Department of Neurosurgery, Aarhus University Hospital
Aarhus, Denmark Recruiting -
Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet
Copenhagen, Denmark Recruiting -
Department of Neurosurgery, Odense University Hospital
Odense, Denmark Recruiting
Study contacts
- Study coordinator: Carsten R Bjarkam, Professor, Ph.D., DMSc.
- Email: c.bjarkam@rn.dk
- Phone: 45+ 211671
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-Thermal Plasma Used During Surgery to Help Prevent Recurrent Chronic Subdural Hematoma
A randomized trial tests whether applying non-thermal plasma during standard surgery to drain a chronic subdural hematoma can reduce recurrence within 6 months.
-
Effect of positioning after surgery on chronic subdural hematoma recurrence
This study tests if lying in a specific position after surgery can help prevent chronic subdural hematomas from coming back in patients.
-
Using body posture to prevent recurrence of chronic subdural hematoma after surgery
This study is testing if certain sleeping positions can help prevent chronic subdural hematomas from coming back after surgery.
-
Middle Meningeal Artery Embolisation to Prevent Recurrence of Chronic Subdural Hematoma
This study tests whether embolising the middle meningeal artery around the time of hematoma evacuation can reduce recurrence in adults with chronic subdural hematoma.
-
What causes vulnerability in older adults with serious diseases and how it affects care decisions
This study tests how often vulnerability factors appear in older adults with serious illnesses and how these factors influence treatment timing, survival, and quality of life.
-
Ready for Safe Cancer Treatment (RESET): A comprehensive perioperative program for surgical patients
The RESET program tests a structured, multidisciplinary perioperative plan to improve safety and recovery for adults having planned cancer surgery and older adults having planned non cancer-related surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.